Introduction.
continuously into pregnant rats between days 17 and 21 of pregnancy. The findings in the fetuses were obtained by quantitative analysis of extracts (Extrelut) of total fetal body lipids ; the extracts were purified on Sep Pak and vitamin D sterols were further separated by high-pressure liquid chromatography. Three hours after the dams were injected with 25-OH-D 3 , the maternal plasma concentration (mean + SD) of 1,2510H) Z D 3 was 221 ± 84 pg/ml. In NX pregnant rats, the 1,2510HI Z D 3 levels were still elevated : 95.6 + 49.0 pg/ml vs 45 ± 22 pg/ml in control rats. In fetuses from intact or NX dams, the levels of 25-OH-D 3 and 1,25(OH) 2 D 3 were not different from the results obtained in the control fetuses but 24,25(OH) 2 D 3 concentrations were increased (6.7 + 1.2 ng vs 2.2 ± 0.7 ng/g body weight). After maternal infusion of 2 or 6 ng/day of 1,25(OHI Z D 3 (n = 8), plasma concentrations (mean + SD) of the metabolite were 64+31 and 517 + 356 pg/ml, respectively, the second being significantly higher than that of the control rats ; 25-OH-D 3 and 24,25(OH) 2 D 3 levels did not change. 1,2510H1 2 D 3 contents (mean ± SD) in fetuses from the treated dams were not different from those of control fetuses 110 ± 2 pg/g body weight).
Our results suggest that pregnant rats and their fetuses were protected against an Introduction.
Recently, plasma levels of 1,25-dihydroxycholecalciferol (1,2510H1 2 D 3 ) have been reported to be significantly elevated in rats (Pike et al., 1979) and in humans (Kumar et al., 1979) (Weisman et al., 1976 ; Noff and Edelstein, 1978 (Gray et al., 1979 (Gray et al., , 1981 Weisman et al., 1978) in vitamin D-deficient pregnant rats and in vitro in the human decidua and placenta (Weisman et al., 1979 25-OH-D 3 concentrations were reduced in both the maternal plasma and the fetal body after 25-OH-D 3 was administered to the dams ; the metabolite seemed to be preferentially 1a-hydroxylated in pregnant rats by either the maternal kidney and/or the placenta. The 25-OH-D 3 levels in the fetuses reflect those in the maternal plasma. Haddad et al. (1971) showed that 1 h after 25-OH-D 3 administration to intact vitamin D-repleted rats, their fetuses only contained 2 % of the dose administered in the form of 3 H-25-OH-D 3 but that more polar metabolites were already present. 
